Sugi Predict

Sugi Predict / Compounds / SCHEMBL30438175

SCHEMBL30438175

SCHEMBL30438175

N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 14/20 0.53
▸ NPY1R P25929 8/20 0.53
▸ NPY2R P49146 6/20 0.53
▸ NPY5R Q15761 5/20 0.53
▸ NOD1 Q9Y239 3/20 0.45
▸ DPP7 Q9UHL4 1/20 0.39
▸ OTC P00480 1/20 0.38
▸ NRP1 O14786 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29769330 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL29769333 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL29400897 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL29556958 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL31264971 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL12533211 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL30176190 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL10001721 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL29769328 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1
SCHEMBL29892693 1.00 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230285594-A1 COMPLEXATION OF NUCLEIC ACIDS WITH DISULFIDE-CROSSLINKED CATIONIC COMPONENTS FOR TRANSFECTION AND IMMUNOSTIMULATION CureVac SE (DE) 2023-09-14 — — US disclosed
US-11690910-B2 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen CureVac SE (DE) 2023-07-04 — — US disclosed